Stock listing
Summit Therapeutics Inc.
- Ticker
- BMV:SMMT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
About Summit Therapeutics Inc.
Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.
Latest news from Summit Therapeutics Inc.
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
Oct 5, 2026
Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types
Oct 2, 2026
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Oct 2, 2026
AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics
Sep 28, 2026